Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-29 4:10 pm Sale |
2025-01-28 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 1,050,053 21.900% |
-7 (-0.00%) |
Filing History |
| 2025-01-16 8:22 pm Purchase |
2025-01-14 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 1,050,060 29.600% |
772,263 (+278.00%) |
Filing History |
| 2025-01-10 7:39 pm Purchase |
2025-01-07 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 277,797 9.990% |
277,797 (New Position) |
Filing History |
| 2024-12-16 7:51 pm Purchase |
2024-12-12 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 18,401,313 17.600% |
212,856 (+1.17%) |
Filing History |
| 2024-11-14 07:00 am Sale |
2024-09-30 | 13G | Arvinas, Inc. ARVN |
RTW Investments, LP | 2,782,329 4.100% |
-1,431,154 (-33.97%) |
Filing History |
| 2024-11-14 06:58 am Purchase |
2024-09-30 | 13G | Immunic, Inc. IMUX |
RTW Investments, LP | 5,594,479 6.100% |
1,259,224 (+29.05%) |
Filing History |
| 2024-11-14 06:56 am Purchase |
2024-09-30 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 3,261,496 7.400% |
962,834 (+41.89%) |
Filing History |
| 2024-11-14 06:53 am Purchase |
2024-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
RTW Investments, LP | 5,941,456 9.990% |
5,941,456 (New Position) |
Filing History |
| 2024-11-14 06:51 am Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 5,919,435 8.500% |
2,326,676 (+64.76%) |
Filing History |
| 2024-11-14 06:48 am Purchase |
2024-09-30 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
RTW Investments, LP | 13,707,506 8.300% |
2,453,955 (+21.81%) |
Filing History |
| 2024-11-14 06:46 am Purchase |
2024-09-30 | 13G | 89bio, Inc. ETNB |
RTW Investments, LP | 7,378,548 7.000% |
1,799,617 (+32.26%) |
Filing History |
| 2024-11-14 06:44 am Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
RTW Investments, LP | 4,930,204 9.990% |
3,203,396 (+185.51%) |
Filing History |
| 2024-11-14 06:42 am Sale |
2024-09-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
RTW Investments, LP | 1,968,002 2.100% |
-4,919,084 (-71.42%) |
Filing History |
| 2024-11-14 06:40 am Sale |
2024-09-30 | 13G | Immunocore Holdings plc IMCR |
RTW Investments, LP | 4,869,798 9.700% |
-1,226,589 (-20.12%) |
Filing History |
| 2024-11-14 06:37 am Purchase |
2024-09-30 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC |
RTW Investments, LP | 742,500 8.300% |
742,500 (New Position) |
Filing History |
| 2024-11-14 06:34 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
RTW Investments, LP | 6,818,641 6.800% |
6,818,641 (New Position) |
Filing History |
| 2024-11-14 06:32 am Purchase |
2024-09-30 | 13G | Immatics N.V. IMTX |
RTW Investments, LP | 10,000,000 9.700% |
10,000,000 (New Position) |
Filing History |
| 2024-11-14 06:30 am Purchase |
2024-09-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
RTW Investments, LP | 1,993,687 9.200% |
1,993,687 (New Position) |
Filing History |
| 2024-11-14 06:27 am Purchase |
2024-09-30 | 13G | Merus N.V. MRUS |
RTW Investments, LP | 4,169,393 6.100% |
4,169,393 (New Position) |
Filing History |
| 2024-11-14 06:25 am Purchase |
2024-09-30 | 13G | Geron Corporation GERN |
RTW Investments, LP | 44,111,916 7.300% |
44,111,916 (New Position) |
Filing History |